Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTOV1 antisense RNA 2 (PTOV1-AS2)
- Target
- PTOV1-AS2
- Molecular classification
- Long non-coding RNA (lncRNA), Other
01
Overview
PTOV1 antisense RNA 2 (PTOV1-AS2) is a long non-coding RNA (lncRNA) found in humans that does not code for a protein. PTOV1-AS2 was identified as part of a glyco-lncRNA signature predictive of tumor characteristics in head and neck squamous cell carcinoma, and its expression is significantly higher in tumor tissues compared to normal tissues[2]. Its differential expression suggests it may play a regulatory role in the molecular mechanisms underlying certain cancers, and it has been investigated as a potential biomarker for disease presence or prognosis. There is currently no evidence that PTOV1-AS2 is a direct therapeutic target (such as a receptor or enzyme), and there are no known drugs that interact specifically with this lncRNA[2][3]. Note: PTOV1-AS2 should not be confused with the protein-coding PTOV1 (Prostate tumor overexpressed gene 1) or its other noncoding family member PTOV1-AS1[1][4].
- Other names
- PTOV1-AS2PTOV1 antisense RNA 2lncRNA PTOV1-AS2
02
Biological functions
Regulation of gene expressionPotential involvement in tumor biologyOther
03
Disease associations
CancerSpecifically implicated in head and neck squamous cell carcinoma (HNSCC)
04
Biomarkers
Potential biomarker for head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on PTOV1 antisense RNA 2 (PTOV1-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PTOV1 antisense RNA 2 (PTOV1-AS2).